A report published by JAMA indicated that online reviews sway a percentage of patients, but that personal recommendations hold more weight.
A good percentage of consumers are open to visiting a pharmaceutical company website, an online survey shows, despite a persistent undercurrent of distrust for industry.
An Everyday Health-Twitter collaboration will deliver targeted promoted Tweets with health news, seasonal and lifestyle info
Pfizer's online Viagra deal with CVS; reorg at the EMA; Mills moves up at Digitas
A recent paper shows licensing boards may take action for a professional's behavior regardless of whether it is in the context of a professional setting.
Internet trends show fondness for online health information, but no need for docs to take on a third job, Millennium says diabetes device market to grow moderately over five years.
Could an online quiz be the future of continuing medical education? In a twist on the "edu-gaming" phenomenon, Cleveland Clinic and physician site MDLinx aim to answer that question with The Smartest Doc, a daily one-minute quiz that aims to keep doctors up to date on the medical literature by appealing to their competitive spirit.
Weary of FDA foot-dragging on digital and social media guidance for pharmas, a group of 60-some industry digerati have put together guidelines of their own.
Consumers are as worried about online privacy as they are about terrorism, but marketers tracking their surfing habits or mining their emails for insights is the least of their worries, according to a survey by McCann Truth Central.
Boehringer Ingelheim is hoping to create a new Facebook phenomenon with the development of a pharma civilization game that could give industry reputation a shot in the arm.
A survey by Yahoo! and advertising giant BBDO says advertisers need to raise their game in "owned media" like brand.com sites to woo consumers.
Pfizer's Lipitor website touted the efficacy of Caduet, Chantix and Norvasc but failed to balance those claims with risk info for the drugs, according to an "untitled letter" from FDA's Division of Drug Marketing, Advertising and Communication (DDMAC).
Facebook sales reps told pharmas last week that they can no longer disable commenting on their non-brand-specific pages, potentially exposing them to flame warriors, spammers, adverse events reports and discussion of off-label uses that might call down the wrath of DDMAC.
Two of the drug industry's brightest minds in social media, Shwen Gwee and Marc Monseau, are changing jobs, with Gwee leaving Vertex for Edelman and Monseau exiting J&J to open his own firm.
The FDA announced plans to study online consumer advertising for prescription drugs in order to resolve "a number of questions surrounding how to achieve 'fair balance' in online DTC promotion.
Visitors to Crestor.com and PurplePill.com can now hit a "click to chat" button to chat with a live AstraZeneca customer service rep.
Havas Drive has launched a practice focused on developing digital products for persons with disabilities and those undergoing rehabilitative therapies.
Social media "power users" value interaction with healthcare companies want them regulated but around, according to a WEGO Health survey.
Google is looking to catch some of that social networking word of mouth marketing magic with a "+1" button that will appear on all of its search ads, allowing users to flag items for their friends.
The White House wants a national "Do not track" policy - a digital version of the "Do not call" registry - and that's making marketing and advertising policy hands nervous.
Everyday Health is going big on mobile, with 23 apps in six verticals, seeking advantage against its older competitor WebMD.
Sanofi-Aventis US is expanding its social media footprint with a new "Discuss Diabetes" blog and a "WhyInsulin" YouTube channel.
Boehringer Ingelheim is partnering with the Country Music Association for a Tune Up For COPD Songwriting Competition featuring country music stars Billy Ray Cyrus and Patty Loveless.
GlaxoSmithKline and Human Genome Sciences launched a patient community for lupus sufferers and their friends and family, in anticipation of an FDA decision on Benlysta in March.
Novo Nordisk is launching an online support program for diabetes patients, dubbed Cornerstones4Care, that promises patients one-stop shopping for diabetes information and product information.
Patients taking a medication and looking online for health information tend to avoid pharmaceutical company sites, according to an online survey conducted by Accenture.
Contextual advertising firm Vibrant reported 58% growth in pharmaceutical-related revenue in the third quarter.
Biogen Idec and Elan's MS drug Tysabri realized a 15% increase in US revenues during the third quarter (compared with 3Q 2009), a gain at least partially due to larger sales forces and increased patient assistance programs, according to Biogen Idec executives.
Novo Nordisk launched a consumer campaign for Victoza, emphasizing the product's ability to bring down blood sugar levels and body weight in patients with type 2 diabetes. The campaign features print ads and a refurbished website, and marks the first consumer push for the brand since its approval in January.
Pfizer took aim at J&J's Tylenol franchise with a campaign offering free Advil and urging consumers to clean out their medicine cabinets and trash recalled drugs.
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.